Press "Enter" to skip to content

Dr. Reddy’s Laboratories announces the launch of Propofol Injectable Emulsion, USP in the U.S. Market

Reddy’s Laboratories Ltd. today announced the launch of Propofol Injectable Emulsion, USP, a therapeutic equivalent generic version of DIPRIVAN (propofol) Injectable Emulsion, USP, approved by the U.S. Food and Drug Administration (USFDA).

Original source: https://health.economictimes.indiatimes.com/news/pharma/dr-reddys-laboratories-announces-the-launch-of-propofol-injectable-emulsion-usp-in-the-u-s-market/67681848?utm_source=RSS&utm_medium=ETRSS

Also Read:   Canada makes drug price crackdown official over industry opposition